intuniv
takeda pharmaceuticals international ag ireland branch - guanfacin hydroklorid - attention deficit disorder med hyperaktivitet - antiadrenergic agents, centrally acting, antihypertensives, - intuniv is indicated for the treatment of attention deficit hyperactivity disorder (adhd) in children and adolescents 6 17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective. intuniv må brukes som en del av en omfattende adhd behandling program, vanligvis inkludert psykologiske, pedagogiske og sosiale tiltak.
bisoprolol vitabalans 10 mg
vitabalans oy - bisoprololfumarat - tablett - 10 mg
bisoprolol vitabalans 5 mg
vitabalans oy - bisoprololfumarat - tablett - 5 mg
hypoloc 5 mg
menarini international o.l. s.a. - nebivololhydroklorid - tablett - 5 mg
hypoloc comp 5 mg / 12.5 mg
menarini international o.l. sa - nebivololhydroklorid / hydroklortiazid - tablett, filmdrasjert - 5 mg / 12.5 mg
gastrogard 370 mg/ g
boehringer ingelheim animal health nordics a/s - omeprazol - oralpasta - 370 mg/ g
metopocor 1 mg/ ml
macure pharma aps - metoprololtartrat - injeksjonsvæske, oppløsning - 1 mg/ ml
elvanse 30 mg
takeda pharmaceuticals international ag ireland branch - lisdeksamfetamindimesilat - kapsel, hard - 30 mg
elvanse 20 mg
takeda pharmaceuticals international ag ireland branch - lisdeksamfetamindimesilat - kapsel, hard - 20 mg
elvanse 40 mg
takeda pharmaceuticals international ag ireland branch - lisdeksamfetamindimesilat - kapsel, hard - 40 mg